Hajj 2025 vaccination requirements

According to the Ministry of Hajj and Umrah, pilgrims must receive all required vaccinations at least 10 days before the Hajj season begins to be eligible for the rituals. Completion of these vaccinations is mandatory to obtain a Hajj permit.

Book cheap flights to Saudi Arabia now

Meningococcal meningitis

All travelers intending to perform Umrah who are one year old and older, from any country, must meet the following vaccine requirements prior coming to the Hajj areas for a period of not less than (10) days:

Travelers must receive either the Meningococcal ACYWX (Polysaccharide conjugate) vaccine or the Meningococcal quadrivalent (ACYW-135) polysaccharide vaccine within the last three years and at least ten days prior to arrival.
Alternatively, travelers can receive the Meningococcal quadrivalent (ACYW-135) conjugated vaccine within the last five years and at least ten days prior to arrival.

Health authorities in the traveler’s country of origin must ensure that the vaccine is administered within its validity period and that the traveler’s vaccination certificate clearly indicates the name, type, and date of administration.

If the vaccine type is not specified on the vaccination certificate, the vaccine will only be considered valid for three years from the date of administration.

Poliomyelitis

All travelers intending pilgrims must adhere to the following poliomyelitis vaccination requirements not less than (4) weeks and not more than (12) months prior to coming to the Kingdom:

Travelers from states reporting WPV1, cVDPV1, or cVDPV3
Travelers coming from countries that have reported cases of Wild Poliovirus type 1 (WPV1), circulating Vaccine-Derived Poliovirus type 1 (cVDPV1), or circulating Vaccine-Derived Poliovirus type 3 (cVDPV3) must receive at least one dose of either the bivalent oral polio vaccine (bOPV) or the inactivated polio vaccine (IPV).
- WPV1: Afghanistan, Pakistan
- cVDPV1: Mozambique, Democratic Republic of the Congo
- cVDPV3: Guinea

Travelers from states reporting positive cVDPV2
Travelers originating from countries that have reported positive cases of circulating Vaccine-Derived Poliovirus type 2 (cVDPV2) from human samples or acute flaccid paralysis (AFP) cases must receive at least one dose of the inactivated polio vaccine (IPV). If IPV is not available, a certificate of vaccination with at least one dose of a type 2 containing oral polio vaccine, including the novel OPV2, is accepted.
- Angola
- Benin
- Burkina Faso
- Cameroon
- Central African Republic
- Chad
- Democratic Republic of the Congo
- Ethiopia
- Guinea
- Indonesia
- Kenya
- Liberia
- Mali
- Mauritania
- Niger
- Nigeria
- Palestine
- Republic of the Congo
- Sierra Leone
- Somalia
- South Sudan
- Tanzania
- Yemen

Yellow fever

All travelers older than nine months from countries or areas at risk of yellow fever transmission must receive the yellow fever vaccine. The countries at risk include:

Africa:
- Angola
- Benin
- Burkina Faso
- Burundi
- Cameroon
- Central African Republic
- Chad
- Congo
- Côte d’Ivoire
- Democratic Republic of the Congo
- Equatorial Guinea
- Ethiopia
- Gabon
- Gambia
- Ghana
- Guinea
- Guinea-Bissau
- Kenya
- Liberia
- Mali
- Mauritania
- Niger
- Nigeria
- Senegal
- Sierra Leone
- South Sudan
- Sudan
- Togo
- Uganda
South America:
- Argentina
- Bolivia
- Brazil
- Colombia
- Ecuador
- French Guiana
- Guyana
- Panama
- Paraguay
- Peru
- Suriname
- Venezuela